.png){kind=icon}
.png){kind=icon}
Return
Characteristics and Clinical Outcomes of De Novo and Acquired Uncommon Compound EGFR Mutations in Patients with Advanced Non-Small Cell Lung Cancer: A Brief Report
.png){kind=icon}
OA
AI
K
S
T
DOI：10.1016/j.cllc.2026.05.005.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
: The optimal treatment of uncommon, compound EGFR-mutated NSCLC is poorly defined due to heterogeneous responses to targeted therapies.
Keywords:
NSCLC
lung cancer
EGFR
atypical EGFR
compound
uncommon EGFR
precision oncology
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.3
Papers:
2.4K
Citations:
4.5K
Organization
Cited Papers